Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
3.670
-0.040 (-1.08%)
At close: Dec 30, 2024, 4:00 PM
4.700
+1.030 (28.07%)
After-hours: Dec 30, 2024, 7:59 PM EST
Verastem Market Cap
Verastem has a market cap or net worth of $163.34 million as of December 30, 2024. Its market cap has decreased by -16.92% in one year.
Market Cap
163.34M
Enterprise Value
91.59M
1-Year Change
-16.92%
Ranking
Category
Stock Price
$3.67
Market Cap Chart
Since January 27, 2012, Verastem's market cap has decreased from $213.30M to $163.34M, a decrease of -23.42%. That is a compound annual growth rate of -2.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 165.10M | -19.74% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 705.19B |
| UnitedHealth Group | 469.34B |
| Novo Nordisk | 393.39B |
| Johnson & Johnson | 349.23B |
| AbbVie | 314.57B |
| Merck & Co. | 252.20B |
| AstraZeneca | 204.17B |
| Thermo Fisher Scientific | 201.22B |